Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices

embody vs Medvi vs welludr: $49, $99 or $41?

Last updated: Sep 1, 2026

Medically reviewed on

How we review

We may earn a commission from links on this page - it never affects our rankings (how we stay objective).

Here’s the short version

welludr is the cheapest at $41/month - a rate that locks on a 12-month plan. embody's $49 is flat with zero commitment and a refund if a provider doesn't approve you. Medvi's $99 promo is the all-inclusive, high-touch option - video visits, free dietician, care coaching.

embody logo
Licensed US telehealth

Compounded GLP-1 from $49/month; not FDA-approved, free expedited delivery

Visit embody
Medvi logo
Licensed US telehealth

Summer Sale! up to $100 off

Visit Medvi
welludr logo
Licensed US telehealth

AI-driven telehealth: compounded GLP-1/GIP + longevity care

Visit welludr

embody vs Medvi vs welludr: side by side

Real published prices and terms - the differences that actually decide this matchup.

embodyMedviwelludr
Semaglutide$49/mo, flat at every dose$99/mo promo (reg. $199), all-inclusive$41/mo (12-month plan), same price at every dose
Tirzepatide$99/mo$166/mo promo (reg. $299)$71/mo
Billing & commitmentMonthly - no commitment, cancel anytimeMonthly, all-inclusive - no surprise charges; HSA/FSA approvedMonthly billing - best rate locks on a 12-month plan
ShippingFree 1-2 day, tracked & insuredFree shippingFree, every 4 weeks, discreet packaging
SupportLicensed doctors, medical director & nursing teamVideo visits + free dietician & care coachingMedical Weight-Care Coach on every plan
Guarantee / refundFull refund if you're not approved-Weight-loss warranty (terms on site)
StandoutLegitScript-certified; 503A pharmaciesAll-inclusive price; HSA/FSA approved1M+ patients; board-certified specialists

Our verdict

Decide on commitment first, support second. Ready to commit to a year: welludr - the $41 lock is the best per-month rate in the market, and its weight-loss warranty backs the plan. Not ready to commit to anything: embody - $49 flat, cancel anytime, refunded if not approved. Know from experience that you quit without someone checking in: Medvi - the $30 premium over embody buys video visits, a dietician and coaching. All three prescribe the same compounded semaglutide after a licensed-provider review.

embody vs Medvi vs welludr: FAQs

Which is cheapest: embody, Medvi or welludr?

For compounded semaglutide: welludr at $41/month (the rate locks on a 12-month plan), embody at $49/month flat with no commitment, Medvi at $99/month promotional (regularly $199) all-inclusive. For tirzepatide: welludr $71, embody $99, Medvi $166 promotional (regularly $299).

Which is best if I don't want a commitment?

embody - $49/month flat, billed month to month, cancel anytime, and a full refund if a licensed provider doesn't approve you for treatment. Medvi also bills monthly with no prepaid term. welludr's best rate ($41) requires a 12-month plan.

Do any of the three offer a guarantee?

welludr backs treatment with a weight-loss warranty (terms on its site), and embody refunds you in full if you're not approved. Medvi doesn't advertise a results guarantee - its pitch is the all-inclusive support model instead.

Break it down two at a time

The head-to-head comparisons between these providers.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)